Impurity Identification and Structure Elucidation in Drug Development: Case Studies

Webinars2026-06-30

This webinar elaborates on the critical decision points for oligonucleotide drugs across the IND-to-FIH phase from three key perspectives: non-clinical evaluation, clinical translation and CMC development, with reference to real-world cases. It is designed to deliver a practical risk prediction framework for R&D teams, and effectively improve the success rate of translating oligonucleotide candidates from laboratory research to first-in-human trials.

Webinars2026-01-06

During the analytical R&D and quality studies of Active Pharmaceutical Ingredients (APIs), the identification and control of unknown impurities is a critical step for ensuring drug safety.This webinar will share practical strategies for high-efficiency impurity purification and share the experience of the efficient separation and precise preparation of impurities from complex matrices using effective modern chromatographic techniques (e.g., HPLC).